Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

olpadronate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PURPOSE Metastatic bone disease is one of the major causes of morbidity and mortality in prostate cancer patients… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2006
2006
BACKGROUND Periodontitis is characterized by gingival inflammation, periodontal pocket formation, and bacterial plaque that lead… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Non-randomised studies have suggested beneficial effects of bisphosphonates in osteogenesis imperfecta. We assessed… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Bisphosphonates (BPs) are pyrophosphate analogues in which the oxygen in P-O-P has been replaced by a carbon, resulting in a… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Bisphosphonates (Bps), inhibitors of osteoclastic bone resorption, are used in the treatment of skeletal disorders. Recent… Expand
Is this relevant?
1998
1998
Prostate cancer is predominantly associated with osteoblastic bone metastases, but an increase in bone resorption has been… Expand
Is this relevant?
1997
1997
Abstract Osteoporosis is an important feature of osteogenesis imperfecta (OI). So far, no effective medical treatment is… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Bisphosphonates are used with increasing frequency in the management of skeletal complications in patients with breast cancer. In… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
1995
1995
As part of a safety-assessment study, doses of 8, 40, and 200 mg/kg per day, 6 days per week, of sodium olpadronate (dimethyl-APD… Expand
Is this relevant?